Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.
Address
60 LEVERONI COURT
NOVATO, CA 94949
Founded
2010
Number of Employees
1,276
Website
http://www.ultragenyx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)